Immunosuppression of thyroiditis

Endocrinology

Volumn 137, Issue 6, 1996, Pages 2199-2207

  Guimaraes, Valeria C ^a   Quintans, Jose ^a   Fisfalen, Maria Elena ^a   Straus, Francis H ^a   Fields, Patrick E ^a   Medeiros Neto, Geraldo ^b   Degroot, Leslie J ^a,c  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FREUND ADJUVANT; MYELIN BASIC PROTEIN; THYROGLOBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CELL PROLIFERATION; CLONAL ANERGY; CONTROLLED STUDY; DRUG EFFECT; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; THYROID DISEASE; THYROIDITIS;

EID: 0029933769     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.6.8641166     Document Type: Article

References (26)

1. Wells H 1911 Studies on the chemistry of anaphylaxis. III. Experiments with isolated proteins, especially those of hen's egg. J Infect Dis 9:147-151
2. Chase MW 1946 Inhibition of experimental drug allergy by prior feeding of sensitizing agent. Proc. Soc. Exp. Biol. Med 61:257-259
3. Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM, Hafler DA 1993 Double blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259:1321-1323.
4. Trentham DE, Dynesius-Trentham A, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, Hafler DA, Weiner HL 1993 Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261:1727-1730
5. Muir A, Schatz DA, Pozzilli P, MacLaren NK 1993 Intervention therapies for insulin-dependent diabetes. Autoimmunity 16:301-310
6. Guimaraes VC, Quintans J, Fisfalen M-E, Straus FE, Wilhelm K, Medeiros-Neto GA, DeGroot LJ 1995 Suppression of development of experimental autoimmune thyroiditis by oral administration of thyroglobulin. Endocrinology 136:3353-3359
7. Whitacre CC, Gienapp IE, Orosz CG, Bitar DM 1991 Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol 147:2155-2163
8. Melamed D, Friedman A 1993 Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur J Immunol 23:937-942
9. Critchfield JM, Racke MK, Zuniga-Pflucker JK, Cannella B, Raine RS, Goverman J, Lenardo MJ 1994 T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263:1139-1143
10. Chen Y, Kuchroo VK, Inobe J-I, Hafler DA, Weiner HL 1994 Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237-1240
11. Friedman A, Weiner HL 1994 Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 91:6688-6692
12. + T lymphocytes. J Immunol 142:748-752
13. Miller A, Lider O, Weiner HL 1991 Antigen-driven bystander suppression after oral administration of antigens. J Exp Med 174:791-198
14. Smith DM, Stuart FP, Wemhoff GA, Quintans J, Fitch FW 1988 Cellular pathways for rejection of class-1-MHC-disparate skin and tumor allographs. Transplantation 45:168-175
15. Gajewski TF, Joyce J, Fitch FW 1989 Antiproliferative effect of IFNγ in immune regulation. J Immunol 143:15-22
16. Mossmann TR, Coffman RL 1989 TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173
17. DeGroot LJ, Quintans J 1989 The causes of autoimmune thyroid disease. Endocr Rev 10:536-562
18. Weiner HL, Friedman A, Miller A, Khoury SJ, Al-Sabbagh A, Santos L, Sayegh M, Nussenblatt RB, Trentham DE, Hafler DA 1994 Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 12:809-837
19. Sydora BC, Mixter PF, Holcombe HR, Eghtesady P, Williams K, Amaral MC, Nel A, Kronenberg A 1993 Intestinal intraepithelial lymphocytes are activated and cytolytic but do not proliferate as well as other T cells in response to mitogenic signals. J Immunol 150:2179
20. Wick MJ, Pfeifer JD, Findlay KA, Harding CV, Normark SJ 1993 Compartmentalization of defined epitopes expressed in Escherichia coli has only a minor influence on efficiency of phagocytic processing for presentation by class I and class II major histocompatibility complex molecules to T cells. Infect Immun 61: 4848-4856
21. Pfeifer JD, Wick MJ, Roberts RL, Findlay K, Normark SJ, Harding SJ 1993 Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361:359-362
22. Lewis M, Fuller BE, Giraldo AA, Kong YC 1992 Resistance to experimental autoimmune thyroiditis is correlated with the duration of raised thyroglobulin levels. Clin Immunol Immunopathol 64:197-204
23. + suppressor T cells in vaccination-induced suppression of murine experimental autoimmune thyroiditis. Clin Immunol Immunopathol 60:484-494
24. Miller A, Al-Sabbagh A, Santos LMB, Das MP, Weiner HL 1993 Epitopes of myelin basic protein that trigger TGF-β release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J Immunol 151: 7307-7315
25. Al-Sabbagh A, Miller A, Santos LM, Weiner HL 1994 Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse. Eur J Immunol 24:2104-2109
26. Khoury SJ, Hancock WW, Weiner HL 1992 Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor, interleukin-4, and prostaglandin E expression in the brain. J Exp Med 176:1355-1364